跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,075 条关于
“MSIG Singapore”
全部
1,075
临床试验
418
药物
94
机构
105
资讯
458
DHFR inhibitors (National University of Singapore)
CD137L-DC-EBV-VAX(National University Hospital, Singapore)
PIKA COVID-19 vaccine(Yisheng Biopharma (Singapore) Pte. Ltd.)
ADCC-R-Epo-R T-cells(National University Hospital, Singapore)
Biotech
Approved
Influenza B virus B/Singapore/WUH4618/2021 antigen (MDCK cell derived, propiolactone inactivated)
(Flucelvax Quadrivalent)
PCART-3
PCART7-CD3
Biotech
Approved
Influenza A virus A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) antigen (formaldehyde inactivated)
(Fluzone High-dose, Fluzone Quadrivalent)
Biotech
Approved
Influenza A virus A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) antigen (UV, formaldehyde inactivated)
Biotech
Approved
Influenza A virus A/Singapore/gp1908/2015 IVR-180 (H1N1) antigen (propiolactone inactivated)
第 1 页,共 10 页
上一页
下一页